Price Cap on Medicines: The Right Solution for Patients
Price cap on medicines is crucial to prevent steep markups and ensure affordable healthcare for all.
Price cap on medicines is crucial to prevent steep markups and ensure affordable healthcare for all.
FDA approval of WELTRUZA marks a significant achievement for Medincell in the pharmaceutical industry.
Rare disease portfolio growth is crucial for pharma companies. Explore Shionogi’s $2B acquisition of IntraBio and its implications.
Explore FDA-regulated clinical trials and Dr Kenneth Pettine’s role in advancing medical innovation.
Discover why retatrutide UK has attracted attention in medical research and its potential in metabolic health.
Aurobindo Pharma acquisition raises questions about growth and strategy. Discover the implications of this significant business move.
Bliss GVS Pharma acquisition marks a significant shift in the market dynamics.
Milestone Pharmaceuticals stock remains steady at $0.92 following China approval, showing potential for growth in the pharmaceutical market.
